Dr Reddy's director reports indirect share holdings

DR REDDYS LABORATORIES LTD director G V Prasad has filed an initial insider ownership report showing indirect holdings of the company’s equity shares.

Accepted by SEC EDGAR 03/20/2026 - 02:13 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director G V Prasad has filed an initial insider ownership report showing indirect holdings of the company’s equity shares. The filing lists 12,717,090 equity shares held through “Gunupati Venkateswara Prasad HUF” and 96,095,920 equity shares held through the “GVP Family Trust (as a Trustee)”. These are reported as indirect positions rather than personal direct holdings and do not reflect any new buy or sell transactions.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Prasad G V

Role Director

Type	Security	Shares	Price	Value
Holding	Equity shares	--	--	--
Holding	Equity shares	--	--	--

Holdings: Equity shares — 12,717,090 shares (Indirect, By Gunupati Venkateswara Prasad HUF); Equity shares — 96,095,920 shares (Indirect, By GVP Family Trust ( as a Trustee))

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DR REDDYS (RDY) Form 3 filing by G V Prasad show?

The Form 3 shows that director G V Prasad reports indirect ownership of DR REDDYS equity shares. It lists 12,717,090 shares via Gunupati Venkateswara Prasad HUF and 96,095,920 shares via the GVP Family Trust, with no buy or sell transactions reported.

How many DR REDDYS (RDY) shares are held through Gunupati Venkateswara Prasad HUF?

The filing reports that 12,717,090 equity shares of DR REDDYS are held indirectly through “Gunupati Venkateswara Prasad HUF.” This reflects an indirect ownership position attributed to that entity rather than a direct personal holding by G V Prasad.

What is the GVP Family Trust’s reported holding in DR REDDYS (RDY)?

According to the Form 3, 96,095,920 equity shares of DR REDDYS are held indirectly through the “GVP Family Trust (as a Trustee).” These shares are attributed as indirect ownership connected to director G V Prasad, rather than as directly held shares.

Does the DR REDDYS (RDY) Form 3 indicate any insider buying or selling?

The Form 3 does not show any insider buying or selling activity. It records existing indirect holdings of equity shares through two entities, with transaction codes and share amounts for trades left blank, indicating no reported purchase or sale events.

Is G V Prasad a director or officer of DR REDDYS (RDY) in this filing?

In this filing, G V Prasad is identified as a director of DR REDDYS LABORATORIES LTD. The officer and ten percent owner boxes are not indicated, and the reported holdings are shown as indirect through a HUF entity and a family trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Prasad G V

(Last) (First) (Middle)

8-2-337, ROAD NO. 3

(Street)

BANJARA HILLS HYDERABAD 500-034

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity shares	12,717,090	I	By Gunupati Venkateswara Prasad HUF
Equity shares	96,095,920	I	By GVP Family Trust ( as a Trustee)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ G V PRASAD	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)